This work is aimed at developing an understanding of enzyme mechanisms through the design of transition state analogs, that resemble activated intermediates in substrate transformations catalyzed by enzymes. Because transition state analogs are chemically stable and cannot collapse to form products, their affinities for enzymes persist, and they are exceptionally potent metabolic inhibitors. In addition, structural observations on their complexes with enzymes can reveal the origins of their unusual affinities for enzymes, which parallel the interactions that are responsible for the catalytic rate enhancements that enzymes bring about. Targets proposed for inhibitor design include three enzymes involved in purine biosynthesis: adenylosuccinate synthetase, inosinic acid dehydrogenase and guanylate synthetase (XMP aminase); in each of the cases there is evidence of a high-energy intermediate whose structure can in principle be imitated with one or more stable analogs that we intend to prepare. Bisubstrate analogs are to be prepared for three kinases that are active in rapidly-dividing cells: thymidine kinase, thymidylate kinase and tyrosine-specific protein kinases. In view of evidence that pyridoxal-requiring enzymes proceed through planar intermediates, a planar bisubstrate analog is to be prepared as a potential inhibitor of pyridoxamine pyruvate transaminase. Finally, experiments relating to the production and purification of new enzyme activities are proposed, using transition state analogs as templates and as eluting agents for chromatographic separation of molecules according to their catalytic turnover numbers.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM018325-17
Application #
3269247
Study Section
Biochemistry Study Section (BIO)
Project Start
1980-07-01
Project End
1990-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
17
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lewis Jr, Charles A; Shen, Lin; Yang, Weitao et al. (2017) Three Pyrimidine Decarboxylations in the Absence of a Catalyst. Biochemistry 56:1498-1503
Lewis Jr, Charles A; Crayle, Jesse; Zhou, Shuntai et al. (2016) Cytosine deamination and the precipitous decline of spontaneous mutation during Earth's history. Proc Natl Acad Sci U S A 113:8194-9
Carter Jr, Charles W; Wolfenden, Richard (2016) tRNA acceptor-stem and anticodon bases embed separate features of amino acid chemistry. RNA Biol 13:145-51
Wolfenden, Richard; Lewis Jr, Charles A; Yuan, Yang et al. (2015) Temperature dependence of amino acid hydrophobicities. Proc Natl Acad Sci U S A 112:7484-8
Carter Jr, Charles W; Wolfenden, Richard (2015) tRNA acceptor stem and anticodon bases form independent codes related to protein folding. Proc Natl Acad Sci U S A 112:7489-94
Wolfenden, Richard (2014) Massive thermal acceleration of the emergence of primordial chemistry, the incidence of spontaneous mutation, and the evolution of enzymes. J Biol Chem 289:30198-204
Wolfenden, Richard (2014) Primordial chemistry and enzyme evolution in a hot environment. Cell Mol Life Sci 71:2909-15
Lewis Jr, Charles A; Wolfenden, Richard (2014) The nonenzymatic decomposition of guanidines and amidines. J Am Chem Soc 136:130-6
Zhou, Xin; Chou, Tsui-Fen; Aubol, Brandon E et al. (2013) Kinetic mechanism of human histidine triad nucleotide binding protein 1. Biochemistry 52:3588-600
Lohman, Danielle C; Edwards, David R; Wolfenden, Richard (2013) Catalysis by desolvation: the catalytic prowess of SAM-dependent halide-alkylating enzymes. J Am Chem Soc 135:14473-5

Showing the most recent 10 out of 28 publications